Thimerosal and autism? A plausible hypothesis that should not be dismissed☆
Received 14 August 2003; accepted 24 November 2003.
Abstract
The autism–mercury hypothesis first described by Bernard et al. has generated much interest and controversy. The Institute of Medicine (IOM) reviewed the connection between mercury-containing vaccines and neurodevelopmental disorders, including autism. They concluded that the hypothesis was biologically plausible but that there was insufficient evidence to accept or reject a causal connection and recommended a comprehensive research program. Without citing new experimental evidence, a number of observers have offered opinions on the subject, some of which reject the IOM's conclusions. In a recent review, Nelson and Bauman argue that a link between the preservative thimerosal, the source of the mercury in childhood vaccines, is improbable. In their defense of thimerosal, these authors take a narrow view of the original hypothesis, provide no new evidence, and rely on selective citations and flawed reasoning. We provide evidence here to refute the Nelson and Bauman critique and to defend the autism–mercury hypothesis.
Safe Minds (Sensible Action For Ending Mercury-Induced Neurological Disorders), 14 Commerce Drive, PH Cranford, New Jersey 07016, USA
Corresponding author. Present address: 22 Fayerweather Street, Cambridge, MA 02138, USA. Tel.: +1-617-973-1270; fax: +1-617-973-1339
☆ A response to: Nelson KB, Bauman ML. Thimerosal and autism? Pediatrics 2003;111(3):674–79.